Dividend income
3.71 $
Earnings per share
18.35 $
Price/earnings (P/E)
14.36 $
Capitalization
38.16 billion $
Sector
Healthcare
Shares outstanding
144.82 million
Capitalization
38.16 billion $
Price/earnings (P/E)
14.36 $
Earnings per share
18.35 $
Dividend rate
-
Dividend income
3.71 $
Biogen Inc. - develops, manufactures and commercializes therapeutics with a focus on neurology, oncology and immunology. The companys products are designed to treat diseases such as multiple sclerosis, non-Hodgkins lymphoma, rheumatoid arthritis, Crohns disease and psoriasis. The company conducts innovative research in an attempt to find cures for diseases that are still considered incurable.